Format for Printing from Your Browser, MS-Word, LaTeX, rich LaTeX

Curriculum vitae

Department/Faculty/University
  • Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, School of Medicine
Function, current position
  • Medical Oncology Specialist (Division of Solid Tumor Oncology), Associate Professor
Education and academic qualifications
  • 2016: Associate Professor of Oncology
  • 2015: ESMO Examination in Medical Oncology
  • 2009-2014: Specialty Training in Medical Oncology
  • 2010-2012: Ph.D. in Oncology
    Thesis: "New diagnostic and therapeutic methods in selected rare hematooncological diagnoses"
  • 2003-2009: M.D. in General Medicine (passed with honours)
Professional experience
  • Since 2010: Lecturer
    Masaryk University, School of Medicine
  • Since 2009: Physician
    Department of Internal Medicine, Hematology and Oncology, University Hospital Brno
Teaching activities
  • Internal Medicine, Oncology
Academic activities
  • 90 scientific publications (of which 41 as the first author)
  • 57 cumulative impact factor
  • 175 citations
  • Projects:
    Evaluation of MET Expression and Inhibition in Squamous Cell Carcinomas of the Head and Neck (ESMO)
    Register of Very Rare Hematooncologic Diseases in Adult Patients (SUp FNB 2/14)
    Internet Portal for Very Rare Hematologic and Oncologic Diseases (23/14/NAP)
Internship and stays for the purpose of study or work
  • 2015-2016: ESMO Translational Research Fellowship at the Bichat-Beaujon University Hospital in Paris, France
  • 2014: ESMO Clinical Unit Visit fellowship at the Antwerp University Hospital in Belgium
  • 2007-2008: Medical University of Vienna and the Vienna General Hospital, Austria under the Socrates/Erasmus programme
  • 2007: Kliniken Erlabrunn in Germany (surgery, internal medicine)
Research interests
  • Head & Neck Cancer
  • Translational Research
  • Very Rare Diseases - Histiocytic disorders, Castleman disease, Skin manifestations of monoclonal gammopathies, Vasculopathies
Professional Society Memberships
  • European Society for Medical Oncology
  • Czech Society of Internal Medicine
  • Czech Society for Oncology
  • Czech Society of Hematology
Awards Related to Science and Research
  • 2013: Young Investigators' Award during the DGHO 2013 Congress in Vienna
  • 2013: 1st place for the best original article in 2012 from the Czech Society of Internal Medicine
  • 2011: Paul Janssen Award for the most outstanding publication contribution to multiple myeloma
Peer-reviewed journals with IF (first or corresponding author):
  • SZTURZ, Petr, E. RAYMOND and S. FAIVRE. c-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside. Oral oncology. AMSTERDAM: ELSEVIER SCIENCE BV, 2016, vol. 59, AUG 2016, p. "E12"-"E14", 3 pp. ISSN 1368-8375. Available from: https://dx.doi.org/10.1016/j.oraloncology.2016.05.017. URL info
  • SZTURZ, Petr, Pol SPECENIER, Carl VAN LAER, Danielle VAN DEN WEYNGAERT, Bob CORTHOUTS, Laurens CARP, Eric VAN MARCK, Olivier VANDERVEKEN and Jan B. VERMORKEN. Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab. European Archives of Oto-Rhino-Laryngology and Head & Neck. NEW YORK: SPRINGER, 2016, vol. 273, No 6, p. 1629-1636. ISSN 0937-4477. Available from: https://dx.doi.org/10.1007/s00405-015-3673-y. info
  • SZTURZ, Petr and S. FAIVRE. Letter to the editor referring to the publication entitled “The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment” by Pai et al. Oral Oncology. Amsterdam: Elsevier Science BV, 2016, vol. 62, "neuvedeno", p. "e3"-"e4", 2 pp. ISSN 1368-8375. Available from: https://dx.doi.org/10.1016/j.oraloncology.2016.08.007. info
  • ŘEHÁK, Zdeněk and Petr SZTURZ. Comment on: FDG PET in the early diagnosis of large-vessel vasculitis. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER, 2014, vol. 41, No 3, p. 579-580. ISSN 1619-7070. Available from: https://dx.doi.org/10.1007/s00259-013-2662-x. info
  • ŘEHÁK, Zdeněk, Petr SZTURZ, Leoš KŘEN, Zdeněk FOJTÍK and Jaroslav STANÍČEK. Upsampling from aorta and aortic branches: PET/CT hybrid imaging identified 18F-FDG hypermetabolism in inflamed temporal and occipital arteries (Upsampling From Aorta and Aortic Branches PET/CT Hybrid Imaging Identified F-18-FDG Hypermetabolism in Inflamed Temporal and Occipital Arteries). CLINICAL NUCLEAR MEDICINE. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2014, vol. 39, No 1, p. "e84"-"e86", 3 pp. ISSN 0363-9762. Available from: https://dx.doi.org/10.1097/RLU.0b013e3182868aae. info
  • SZTURZ, Petr. Very rare diseases in oncology. Medical oncology. Totowa: HUMANA PRESS INC, 2014, vol. 31, No 5, p. 947-948. ISSN 1357-0560. Available from: https://dx.doi.org/10.1007/s12032-014-0947-y. info
  • SZTURZ, Petr, Zdeněk ADAM, Z. ŘEHÁK and Renata KOUKALOVÁ. Xanthelasma palpebrarum responding to interleukin-1 blockade. Internal medicine journal. Hoboken: Wiley-Blackwell, 2014, vol. 44, No 6, p. 617-618. ISSN 1444-0903. Available from: https://dx.doi.org/10.1111/imj.12441. info
  • SZTURZ, Petr, M. PRÁŠEK, Z. ŘEHÁK and P. FABIAN. Unicentric Castleman disease: from screening mammography to PET/CT imaging. Nuklearmedizin-Nuclear Medicine. Stuttgart: Schattauer GmbH-Verlag Medizin Naturwissenschaften, 2014, vol. 53, No 5, p. "N41"-"N43", 3 pp. ISSN 0029-5566. info
  • SZTURZ, Petr, Zdeněk ADAM, Vladimír VAŠKŮ, Josef FEIT, Marta KREJČÍ, Luděk POUR, Roman HÁJEK and Jiří MAYER. Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment. LEUKEMIA & LYMPHOMA. LONDON: INFORMA HEALTHCARE, 2013, vol. 54, No 6, p. 1324-1326. ISSN 1042-8194. Available from: https://dx.doi.org/10.3109/10428194.2012.738816. info
  • SZTURZ, Petr, Libor HLAVATÝ, Jiří PRÁŠEK and Dana DVOŘÁKOVÁ. Erdheim-Chester disease and Schnitzler syndrome: so near, and yet so far. USA: Springer, 2013. Available from: https://dx.doi.org/10.1007/s12185-013-1437-2. info
  • ADAM, Zdeněk, Petr SZTURZ, Jiří VANÍČEK, Mojmír MOULIS, Luděk POUR, Marta KREJČÍ, Roman HÁJEK and Jiří MAYER. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases. Acta Oncologica. LONDON: INFORMA HEALTHCARE, 2013, vol. 52, No 5, p. 994-1001. ISSN 0284-186X. Available from: https://dx.doi.org/10.3109/0284186X.2012.716164. info
  • SZTURZ, Petr, Zdeněk ADAM, Zdenek REHAK, Renata KOUKALOVÁ, Leoš KŘEN, Mojmír MOULIS, Marta KREJČÍ and Jiří MAYER. Salvage lenalidomide in four rare oncological diseases. Tumori. Roma: PENSIERO SCIENTIFICO EDITOR, 2013, vol. 99, No 5, p. "e251"-"e256", 6 pp. ISSN 0300-8916. Available from: https://dx.doi.org/10.1700/1377.15326. URL info
  • SZTURZ, Petr, Zdeněk ADAM, Zdeněk ŘEHÁK, Renata KOUKALOVÁ, Radka ŠLAISOVÁ, Olga STEHLÍKOVÁ, Jana CHOVANCOVÁ, Martin KLABUSAY, Marta KREJČÍ, Luděk POUR, Roman HÁJEK and Jiří MAYER. Lenalidomide proved effective in multisystem Langerhans cell histiocytosis. Acta Oncologica. 2012, vol. 51, No 3, p. 412-415. ISSN 0284-186X. Available from: https://dx.doi.org/10.3109/0284186X.2011.631581. info
  • SZTURZ, Petr, Zdeněk ŘEHÁK, Renata KOUKALOVÁ, Zdeněk ADAM, Marta KREJČÍ, Luděk POUR, Lenka ZAHRADOVÁ, Jiří VANÍČEK, Tomáš NEBESKÝ, Roman HÁJEK and Jiří MAYER. Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma. Nuclear Medicine and Biology. 2012, vol. 39, No 3, p. 429-436. ISSN 0969-8051. Available from: https://dx.doi.org/10.1016/j.nucmedbio.2011.10.002. info
  • ŘEHÁK, Zdeněk, Petr SZTURZ, Eva KREJČÍ and Ilona KOCÁKOVÁ. FDG-PET-Positive Foreign-Body Granuloma Mimicking Residual Germinal Tumor Infiltration. Clinical Nuclear Medicine. 2012, vol. 37, No 8, p. 790-792. ISSN 0363-9762. Available from: https://dx.doi.org/10.1097/RLU.0b013e3182485291. info
  • SZTURZ, Petr, Zdeněk ADAM, Jana CHOVANCOVÁ, Olga STEHLÍKOVÁ, Martin KLABUSAY, Josef FEIT, Leoš KŘEN, Zdeněk FOJTÍK, Marta KREJČÍ, Luděk POUR, Roman HÁJEK and Jiří MAYER. Cytokine analysis in a patient with relapsing Kikuchi-Fujimoto disease. Leukemia & Lymphoma. LONDON: INFORMA HEALTHCARE, 2012, vol. 53, No 4, p. 743-745. ISSN 1042-8194. Available from: https://dx.doi.org/10.3109/10428194.2011.627482. info
  • SZTURZ, Petr, Zdeněk ADAM, Jana CHOVANCOVÁ, Olga STEHLÍKOVÁ, Martin KLABUSAY, Z. ŘEHÁK, R. KOUKALOVÁ, Lenka ZAHRADOVÁ, Marta KREJČÍ, Luděk POUR, Roman HÁJEK and Jiří MAYER. Lenalidomide: a new treatment option for Castleman disease. Leukemia & Lymphoma. LONDON: INFORMA HEALTHCARE, 2012, vol. 53, No 10, p. 2089-2091. ISSN 1042-8194. Available from: https://dx.doi.org/10.3109/10428194.2011.621564. info
  • SZTURZ, Petr, Zdeněk ADAM, Roman HÁJEK and Jiří MAYER. Successful Anakinra Therapy in 2 Patients with Schnitzler Syndrome. Onkologie. Switzerland: Karger, 2011, vol. 34, No 5, p. 265-268. ISSN 0378-584X. Available from: https://dx.doi.org/10.1159/000327816. URL info
  • SZTURZ, Petr, Zdeněk ADAM, Mária KLINCOVÁ, Josef FEIT, Marta KREJČÍ, Luděk POUR, Lenka ZAHRADOVÁ, Vladimír VAŠKŮ, Roman HÁJEK and Jiří MAYER. Multiple Myeloma Associated IgA Pemphigus: Treatment With Bortezomib- and Lenalidomide-Based Regimen. Clinical Lymphoma, Myeloma & Leukemia. 2011, vol. 11, No 6, p. 517-520. ISSN 2152-2650. Available from: https://dx.doi.org/10.1016/j.clml.2011.06.014. info

2016/09/04


Curriculum vitae: doc. MUDr. Petr Szturz, Ph.D. (učo 101717), version: English(1), last update: 2016/09/04 19:47, P. Szturz